The frequency and nature of spurious pulse oximetry readings were compared using both a conventional pulse oximeter (CPO) and a prototype Masimo signal extraction technology pulse oximeter (Masimo SET'"). At a university hospital, 50 ASA physical status I-IV adult patients who underwent general or spinalepidural anesthesia were selected from a group of 250 patients on the basis of high-alarm generation with routine postoperative pulse oximetry. Pulse oximetry data were recorded simultaneously from both devices with a computer. Overall, the CPO alarm frequency (i.e., oxygen saturation < 90%, or complete signal loss) was once every 13 min, and 87% of these alarms were considered false. Alarms were considered false based on reference electrocardiographs (16 patients), arterial blood gases (7 patients), and clinical assessment. The prototype Masimo SET'" device alarm frequency was once every 30 min, and 59% of these were considered false. During arm motion with 15 patients, the CPO device produced spurious signals on 54 occasions compared with five for the prototype Masimo SET'". The incidence of artifactual pulse oximetry events during patient motion appear to be substantially reduced with the prototype Masimo SET'" device, relative to a CPO device. (Anesth Analg 1996; 83:269-72) T he pulse oximeter has been part of the anesthetic standard of care since the mid 1980's (1,2). While in most clinical settings it provides continuous oxygen saturation (Spa*) data, in some settings the data are interrupted due to low signal-to-noise ratios. Under conditions of low perfusion (low signal) (3,4) or patient motion (high noise) (5-10) spurious desaturation reports or outright oximeter failure can result. In the postanesthesia care unit (PACU) setting, Wiklund et al. (11) have observed an average pulse oximeter alarm frequency of once every 8 min (77% of these were attributed to motion or low perfusion). Motion artifact alone was investigated by Trivedi et al. (12) using a motion machine on healthy volunteers. They observed that both 2 and 4 Hz of imposed motion resulted in significant Spo, reading failures.
Recently, a unique technique for handling low signal to noise ratio data has been developed (Masimo Corporation, Mission Viejo, CA Although the Masimo SET'" technology performed well in studies using healthy volunteers, evaluations in clinical settings have not been reported. Therefore, this investigation involved preliminary comparison of a prototype Masimo SET'" device with a conventional pulse oximeter (0'0) in the PACU.
Method
With approval of the investigational review board, 250 patients with ASA physical status I, II, and III were evaluated upon admission to the PACU of an adult university hospital. Fifty patients who were generating alarms with their routine pulse oximeter monitoring (Nellcor N200, Hayward CA) were selected for admission into this study.
The study involved placing disposable adhesive pulse oximeter sensors (Nellcor Oxisensor II D-25) on the index and ring fingers of the patient's arm, which was not subject to occlusion by a noninvasive blood pressure monitor. These sensors were optically shielded from each other to eliminate sensor-to-sensor optical cross-talk and from extraneous light by black Anesth Analg 1996; 83:269-72 plastic finger cots (provided by Masimo Corporation). Each probe was randomly connected to either a CPO (Nellcor N-200) or to a prototype Masimo SET'" pulse oximeter. Data from these devices (Spo, and pulse rate) were recorded each second using a computer. Seven patients had arterial catheters in place which allowed arterial blood sampling for blood gas analysis (Stat Profile 5 Analyzer; Nova Biomedical, Waltham, MA). However, it was difficult to draw blood concurrently with the brief episodes of patient movement. As a result, accuracy was inferred in two ways: 1) Spo, values obtained during these brief disturbances were compared with baseline values observed between disturbances; and 2) independent determination of pulse rate (using electrocardiograph (ECG) or arterial catheter pulse) was compared with pulse oximeter pulse rate (17 patients).
After collection, the data were transferred to spreadsheets and analyzed for frequency and duration of relevant events. All data are presented as mean t SD.
Results
Fifty patients were monitored for 28 2 23 min. With 10 patients exhibiting nonrhythmic motion (i.e., gross arm motion as opposed to tremor or shiver) the Masimo SET'" device failed to give a signal three times for an average duration of 10 + 0.6 s, whereas the CPO device failed 14 times with a mean duration of 46 ? 66 s (Table 1) . Spurious desaturations, accompanied by spurious pulse rate changes, were also observed (Figure la) . On 12 occasions the CPO Spo, was at least 10% lower than the Masimo SET'" Spo,. During these episodes, the Cl'0 pulse rate abruptly changed and/ or did not agree with the ECG heart rate.
During episodes of tremor (i.e., shivering or Parkinsonian tremor) exhibited by five patients, spurious desaturations occurred which were accompanied by spurious heart rates ( Figure lb) . On 26 occasions the CPO Spo, was at least 10% lower than the Masimo SET'" Spo, and these disturbances persisted for 75 & 105 s (Table 1) . On the other hand, this occurred once (for 2 s) with the Masimo SET'" device. Between tremors Spa, and heart rate relative bias were both negligible (Figure lb) . During artifactual desaturations related to patient motion the Masimo SET'" pulse rate remained consistent with the reference rate (obtained by either ECG or arterial catheter pulse) whereas the CPO pulse rate had a much larger bias for the three types of motion exhibited by three patients (Table 2) .
Two modes of low perfusion were observed. One patient locally reduced perfusion in his hand by intermittently clenching his fist in response to pain. This resulted in CEO signal loss on 25 occasions compared with 9 for the Masimo SETTM (Table 1) . Two patients presented with cool extremities which resulted in CPO complete signal loss. The Masimo SET'" device did give readings but with significant bias relative to arterial blood gas measurements. While reading 90%, the Sao, determined by arterial blood gas analysis was 99%. With the second patient, the Masimo SETTM Spo, reading was 74% when the Sao, determined by arterial blood gas analysis was 100%. The conventional pulse oximeter alarm frequency in this study was once every 13 min (Table 3) . Compared with the CPO pulse oximeter, the alarm frequency with the Masimo SETTM device was decreased by a factor of 2. In addition to higher alarm frequency, the CPO false alarm duration (48 ? 95 s) was greater than the Masimo SET'" duration (25 -t 37 s). Therefore, of 1400 min of monitoring 50 patients, the CPO was alarming falsely for 75 min (5.4%) vs 11 min (0.8%) for the Masimo SET'" prototype. This represents a sevenfold decrease in audible false alarming.
Discussion
A variety of methods have been devised to minimize pulse oximetry's loss of signal or false positive alarms associated with motion, low perfusion, ambient light, or some other cause of low signal-to-noise ratio. Most of these involve averaging the signal over longer periods of time and/ or rejecting rapid unphysiologic changes in signal ratio (17). Both techniques may prolong the response time of the device to a true positive alarm, and in some circumstances may even provide a false sense of security if the old data are presented by the oximeter while it is awaiting new data to interpret. The prototype Masimo SET'" technology investigated in this study seems to have reduced this problem significantly. Although loss of signal and false alarms are not eliminated from the data presented here, they appear to be substantially reduced. This was particularly apparent during conditions of gross (nonrhythmic) motion and tremor where a 22-fold reduction in signal loss time was observed. Overall, the Masimo SET'" prototype device produced approximately onehalf the number of alarms that the CPO produced. A possible explanation for the nature of the conventional pulse oximetry failure during tremor involves the confounding contribution of venous blood. CPOs identify the absorbance contribution of arterial blood by its pulsatile (i.e., AC) nature (Equation 1).
wm / DC660 R = AC,,,/DC,,, where AC, = alternating current of light with wavelength i nanometers, DC, = direct current of light with wavelength i nanometers, and R = ratio which can be empirically related to Spo,. During tremor, the venous blood may be falsely identified as pulsatile, and produce a large artifactual contribution. The normal range for mixed venous oxygen saturation is 70%-80%, while peripheral venous saturation may be higher or lower depending on perfusion and oxygen extraction. During Parkinson tremor, the CPO did produce artifactual Spo, approaching 65%, with associated artifactual pulse rate (Figure lb) . In contrast, the Masimo SET'" device was more effective in extracting Spa, and pulse rate from this signal noise.
During random arm motion, the nature of the artifact is thought to occur by a different mechanism. Both the red (660 nm) and infrared (940 nm) signals are associated with noise components (Equation 2).
where Si = signal of light with wavelength i nanometers resulting from arterial blood and Ni = signal of light with wavelength i nanometers resulting from noise. When the noise components become very large (i.e., during random arm motion), then R approaches 1, and this corresponds to approximately 85% oxygen saturation (6). Interestingly, the Spo, did approach 85% during nonrhythmic arm motion (Figure la) . The Masimo SET'" (with its ability to subtract noise components) was much less susceptible to this type of spurious desaturation artifact (Table 1) . During conditions of low perfusion resulting from intermittent fist clenching the prototype Masimo SET'" device was resistant to artifactual desaturation and loss of signal. In the patients who had more constant low perfusion (i.e., Raynaud's syndrome or cool extremities) the CPO device failed to provide readings, while the Masimo SET'" prototype continued to provide Spa, readings, but with an appreciable bias relative to Sao, calculated from blood gas analysis.
Sensors used in this study were optically shielded from each other and from extraneous light. The effects of extraneous light on the performance of the prototype Masimo SET device requires further investigation.
This study showed a marked decrease in loss of signal, false alarms, and false alarm duration with the Masimo SET'" device compared to a conventional pulse oximeter. However, further studies in the clinical setting are required to determine effectiveness with low perfusion. Other settings, such as pediatric recovery, critical care unit monitoring, telemetry monitoring, and intraoperative monitoring in high-risk patients need to be investigated to assess whether this is a technological advance in pulse oximetry that merits increased expense of new monitors or replacement of existing functional monitors.
